Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06567821 · ClinicalTrials.gov registry record · Phase 2
Using Navigation to Improve Accuracy of Maxillary Balloon Sinusotomy
A Phase 2 study of Chronic Maxillary Rhinosinusitis, sponsored by Cedars-Sinai Medical Center.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06567821 is a Phase 2 study of Chronic Maxillary Rhinosinusitis that is actively recruiting participants, run by Cedars-Sinai Medical Center. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06567821, a Phase 2 study of Chronic Maxillary Rhinosinusitis, is actively recruiting participants, sponsored by Cedars-Sinai Medical Center.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the research is to examine the effectiveness of navigation in maxillary sinus balloon dilation for the treatment of chronic maxillary rhinosinusitis.
Conditions Studied
Interventions
- DEVICE RELIEVA SPINPLUS® NAV Balloon Sinusplasty System
Study Locations (1)
California
- Cedars Sinai - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-09-04 |
| Est. Completion | 2027-12-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06567821
The ClinicalTrials.gov registry entry for NCT06567821 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Maxillary Rhinosinusitis appearing as the primary indexed condition, and to 1 intervention - of which RELIEVA SPINPLUS® NAV Balloon Sinusplasty System is the first listed.
NCT06567821 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06567821 about?
NCT06567821 is a clinical study titled "Using Navigation to Improve Accuracy of Maxillary Balloon Sinusotomy". The purpose of the research is to examine the effectiveness of navigation in maxillary sinus balloon dilation for the treatment of chronic maxillary rhinosinusitis.
What is the current status of trial NCT06567821?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2024-09-04. Estimated completion is 2027-12-31.
What conditions does trial NCT06567821 study?
This clinical trial studies the following conditions: Chronic Maxillary Rhinosinusitis.
What interventions are being tested in trial NCT06567821?
The interventions under investigation include: RELIEVA SPINPLUS® NAV Balloon Sinusplasty System (DEVICE).
Who is sponsoring clinical trial NCT06567821?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06567821 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.